Myocardial sympathetic innervation in diabetic patients with symptomatic coronary artery disease

被引:3
|
作者
Fricke, E. [1 ]
Eckert, S. [2 ]
Fricke, H. [1 ]
Koerfer, J. [1 ]
Weisel, R. [1 ]
Lindner, O. [1 ]
Tschoepe, D. [3 ]
Horstkotte, D. [2 ]
Burchert, W. [1 ]
机构
[1] Hertz & Diabet Zentrum Nordrhein Westfalen, Inst Radiol Nukl Med & Mol Bildgebung, D-32545 Bad Oeynhausen, Germany
[2] Hertz & Diabet Zentrum Nordrhein Westfalen, Dept Cardiol, D-32545 Bad Oeynhausen, Germany
[3] Hertz & Diabet Zentrum Nordrhein Westfalen, Ctr Diabet, D-32545 Bad Oeynhausen, Germany
来源
NUKLEARMEDIZIN-NUCLEAR MEDICINE | 2008年 / 47卷 / 01期
关键词
diabetes mellitus; coronary heart disease; sympathetic nervous system; ischoemia; positron emission tomography;
D O I
10.3413/nukmed-0102
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim: In non-diabetic patients, sympathetic innervation can be preserved even if there is major impairment of myocardial blood supply. Matters may be more complex in diabetic patients because denervation can be caused by (cardiac autonomic neuropathy (CAN) or by ischemic injury. Our aim was to determine whether restrictions in myocardial blood supply have a pronounced influence on sympathetic innervation in diabetics and if this effect can be differentiated from CAN. Patients, methods: We analyzed 20 diabetics with advanced coronary artery disease (CAD) and without known CAN. We determined quantitative myocardial blood flow using N-13-ammonia-PET, myocardial viability with F-18-FDG, and cardiac innervation with C-11-HED. We investigated the relationship between regional HED retention, blood flow, and coronary flow reserve (CFR). Attenuated heart rate response to adenosine was taken as indicator for CAN (HR ratio). Results: There was minor correlation of segmental stress flow and HED retention (r(2) = 0.063, p < 0.0001). Correlation improved when stress flow as well as HED retention were normalized to the individual maximum (r(2) = 0.162, p < 0.0001). In nine patients, a HR ratio < 1.2 implicated subdinical CAN. Duration of diabetic disease or glycaemic control (HbAlc) did not correlate with mean HED retention in the viable segments, but with its voriation coefficient. Conclusions: As in non-diabetic patients, a slight correlation exists between CFR and sympathetic innervation. The sensitivity of sympathetic nerves to reductions in CFR does not seem to be increased as compared to the results reported for non-diabetics. Besides impaired blood supply, long duration of diabetic disease and bad glycaemic control also seem to impair sympathetic innervation provoking higher heterogeneity.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 50 条
  • [21] Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease
    Koivuviita, Niina
    Tertti, Risto
    Jarvisalo, Mikko
    Pietila, Mikko
    Hannukainen, Jarna
    Sundell, Jan
    Nuutila, Pirjo
    Knuuti, Juhani
    Metsarinne, Kaj
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) : 2773 - 2779
  • [22] Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients
    Ditchburn, CJ
    Hall, JA
    de Belder, M
    Davies, A
    Kelly, W
    Bilous, R
    POSTGRADUATE MEDICAL JOURNAL, 2001, 77 (908) : 395 - 398
  • [23] Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography
    Chu, Zhi-gang
    Yang, Zhi-gang
    Dong, Zhi-hui
    Zhu, Zhi-yu
    Peng, Li-qing
    Shao, Heng
    He, Ci
    Deng, Wen
    Tang, Si-shi
    Chen, Jing
    CARDIOVASCULAR DIABETOLOGY, 2010, 9
  • [24] Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography
    Zhi-gang Chu
    Zhi-gang Yang
    Zhi-hui Dong
    Zhi-yu Zhu
    Li-qing Peng
    Heng Shao
    Ci He
    Wen Deng
    Si-shi Tang
    Jing Chen
    Cardiovascular Diabetology, 9
  • [25] Ticagrelor in patients with symptomatic peripheral artery disease and prior coronary artery disease
    Berger, J.
    Heizer, G.
    Baumgartner, I.
    Fowkes, F. G. R.
    Held, P.
    Katona, B. G.
    Norgren, L.
    Jones, W. S.
    Lopes, R. D.
    Abramson, B. L.
    Millegard, M.
    Blomster, J.
    Hiatt, W. R.
    Patel, M. R.
    Mahaffey, K. W.
    EUROPEAN HEART JOURNAL, 2017, 38 : 452 - 452
  • [26] PREVALENCE OF SYMPTOMATIC AND SILENT MYOCARDIAL ISCHEMIA DURING EXERCISE IN PATIENTS WITH CORONARY-ARTERY DISEASE
    AMSTERDAM, EA
    MARTSCHINSKE, R
    LASLETT, LJ
    RUTLEDGE, JC
    VERA, Z
    CLINICAL RESEARCH, 1985, 33 (01): : A3 - A3
  • [27] Assessment of coronary artery disease in patients with (a)symptomatic diabetes
    Bax, JJ
    van der Wall, EE
    EUROPEAN HEART JOURNAL, 2006, 27 (06) : 631 - 632
  • [28] Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
    Paulo Cury Rezende
    Rosa Maria Rahmi
    Augusto Hiroshi Uchida
    Leandro Menezes Alves da Costa
    Thiago Luis Scudeler
    Cibele Larrosa Garzillo
    Eduardo Gomes Lima
    Carlos Alexandre Wainrober Segre
    Priscyla Girardi
    Myrthes Takiuti
    Marcela Francisca Silva
    Whady Hueb
    Jose Antonio Franchini Ramires
    Roberto Kalil Filho
    Cardiovascular Diabetology, 14
  • [29] Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients
    Rezende, Paulo Cury
    Rahmi, Rosa Maria
    Uchida, Augusto Hiroshi
    Alves da Costa, Leandro Menezes
    Scudeler, Thiago Luis
    Garzillo, Cibele Larrosa
    Lima, Eduardo Gomes
    Wainrober Segre, Carlos Alexandre
    Girardi, Priscyla
    Takiuti, Myrthes
    Silva, Marcela Francisca
    Hueb, Whady
    Franchini Ramires, Jose Antonio
    Filho, Roberto Kalil
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [30] CORONARY ARTERY DISEASE IN SYMPTOMATIC AND ASYMPTOMATIC PATIENTS ON HEMODIALYSIS
    Wanic-Kossowska, Maria
    Popowska-Drojecka, Julia
    Kobelski, Mikolaj
    Oko, Andrzej
    Koziol, Lidia
    Pawliczak, Elzbieta
    Muszytowski, Marek
    Czekalski, Stanislaw
    NEPHROLOGY, 2005, 10 : A295 - A295